Regulation of hepatic PPARγ2 and lipogenic gene expression by melanocortin

Biochemical and Biophysical Research Communications

Volumn 376, Issue 2, 2008, Pages 384-388

  Poritsanos, Nicole J ^a   Wong, Davie ^a   Vrontakis, Maria E ^a   Mizuno, Tooru M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Fatty liver; Lipogenesis; Melanocortin; Obesity; PPAR ; SREBP 1

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MELANOCORTIN; MESSENGER RNA; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN, MOUSE; INTERMEDIN; MELANOCORTIN RECEPTOR; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; LIPID METABOLISM; LIVER METABOLISM; MALE; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LIPOGENESIS; LIVER; METABOLISM; WHITE ADIPOSE TISSUE;

MUS;

ADIPOSE TISSUE, WHITE; ANIMALS; GENE EXPRESSION REGULATION; LIPOGENESIS; LIVER; MALE; MELANOCORTINS; MELANOCYTE-STIMULATING HORMONES; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; PPAR GAMMA; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 52949113009     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.162     Document Type: Article

References (30)

1. Postic C., and Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118 (2008) 829-838
2. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8 (2005) 571-578
3. Oswal A., and Yeo G.S.H. The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics. Obes. Rev. 8 (2007) 293-306
4. Yen T.T., Allan J.A., Yu P.L., Acton M.A., and Pearson D.V. Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice. Biochim. Biophys. Acta 441 (1976) 213-220
5. Albarado D.C., McClaine J., Stephens J.M., Mynatt R.L., Ye J., Bannon A.W., Richards W.G., and Butler A.A. Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology 145 (2004) 243-252
6. Jones B.H., Kim J.H., Zemel M.B., Woychik R.P., Michaud E.J., Wilkison W.O., and Moustaid N. Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am. J. Physiol. 270 (1996) E192-E196
7. Lin J., Choi Y.H., Hartzell D.L., Li C., Della-Fera M.A., and Baile C.A. CNS melanocortin and leptin effects on stearoyl-CoA desaturase-1 and resistin expression. Biochem. Biophys. Res. Commun. 311 (2003) 324-328
8. Mizuno T.M., Kelley K.A., Pasinetti G.M., Roberts J.L., and Mobbs C.V. Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 52 (2003) 2675-2683
9. Li G., Zhang Y., Rodrigues E., Zheng D., Matheny M., Cheng K.Y., and Scarpace P.J. Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E252-E258
10. Adage T., Scheurink A.J., de Boer S.F., de Vries K., Konsman J.P., Kuipers F., Adan R.A., Baskin D.G., Schwartz M.W., and van Dijk G. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J. Neurosci. 21 (2001) 3639-3645
11. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., Pfluger P.T., Castaneda T.R., Neschen S., Hofmann S.M., Howles P.N., Morgan D.A., Benoit S.C., Szanto I., Schrott B., Schurmann A., Joost H.G., Hammond C., Hui D.Y., Woods S.C., Rahmouni K., Butler A.A., Farooqi I.S., O'Rahilly S., Rohner-Jeanrenaud F., and Tschop M.H. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117 (2007) 3475-3488
12. Kim E.R., Leckstrom A., and Mizuno T.M. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice. Behav. Brain Res. 194 (2008) 66-71
13. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., and Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 (2005) 1343-1351
14. Dentin R., Girard J., and Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87 (2005) 81-86
15. Shimano H., Yahagi N., Amemiya-Kudo M., Hasty A.H., Osuga J., Tamura Y., Shionoiri F., Iizuka Y., Ohashi K., Harada K., Gotoda T., Ishibashi S., and Yamada N. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. 274 (1999) 35832-35839
16. Yamashita H., Takenoshita M., Sakurai M., Bruick R.K., Henzel W.J., Shillinglaw W., Arnot D., and Uyeda K. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. USA 98 (2001) 9116-9121
17. Ishii S., Iizuka K., Miller B.C., and Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. USA 101 (2004) 15597-15602
18. Matsusue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., Brewer Jr. B., Reitman M.L., and Gonzalez F.J. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 111 (2003) 737-747
19. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., Nicol C.J., Vinson C., Gonzalez F.J., and Reitman M.L. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278 (2003) 34268-34276
20. Memon R.A., Tecott L.H., Nonogaki K., Beigneux A., Moser A.H., Grunfeld C., and Feingold K.R. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141 (2000) 4021-4031
21. Bedoucha M., Atzpodien E., and Boelsterli U.A. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J. Hepatol. 35 (2001) 17-23
22. Schadinger S.E., Bucher N.L., Schreiber B.M., and Farmer S.R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1195-E1205
23. Zhang Y.L., Hernandez-Ono A., Siri P., Weisberg S., Conlon D., Graham M.J., Crooke R.M., Huang L.S., and Ginsberg H.N. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J. Biol. Chem. 281 (2006) 37603-37615
24. Lee C.H., Olson P., Hevener A., Mehl I., Chong L.W., Olefsky J.M., Gonzalez F.J., Ham J., Kang H., Peters J.M., and Evans R.M. PPARdelta regulates glucose metabolism and insulin sensitivity. Proc. Natl. Acad. Sci. USA 103 (2006) 3444-3449
25. Matsuzaka T., Shimano H., Yahagi N., Amemiya-Kudo M., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Tomita S., Sekiya M., Hasty A., Nakagawa Y., Sone H., Toyoshima H., Ishibashi S., Osuga J., and Yamada N. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 53 (2004) 560-569
26. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., Sharma R., Hudgins L.C., Ntambi J.M., and Friedman J.M. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297 (2002) 240-243
27. Biddinger S.B., Miyazaki M., Boucher J., Ntambi J.M., and Kahn C.R. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes 55 (2006) 2032-2041
28. Halaas J.L., Boozer C., Blair-West J., Fidahusein N., Denton D.A., and Friedman J.M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 94 (1997) 8878-8883
29. da Silva A.A., Kuo J.J., and Hall J.E. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43 (2004) 1312-1317
30. Tallam L.S., da Silva A.A., and Hall J.E. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48 (2006) 58-64